Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-4 of 4 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER studyRoss, D.; Branford, S.; Seymour, J.; Schwarer, A.; Arthur, C.; Yeung, D.; Dang, P.; Goyne, J.; Slader, C.; Filshie, R.; Mills, A.; Vaz de Melo, J.; White, D.; Grigg, A.; Hughes, T.
2018Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cellsRoss, D.; Pagani, I.; Shanmuganathan, N.; Kok, C.; Seymour, J.; Mills, A.; Filshie, R.; Arthur, C.; Dang, P.; Saunders, V.; Braley, J.; Yong, A.; Yeung, D.; White, D.; Grigg, A.; Schwarer, A.; Branford, S.; Hughes, T.
2017Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesionsSadras, T.; Heatley, S.; Kok, C.; Dang, P.; Galbraith, K.; McClure, B.; Muskovic, W.; Venn, N.; Moore, S.; Osborn, M.; Revesz, T.; Moore, A.; Hughes, T.; Yeung, D.; Sutton, R.; White, D.
2017High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatmentHeatley, S.; Sadras, T.; Kok, C.; Nievergall, E.; Quek, K.; Dang, P.; McClure, B.; Venn, N.; Moore, S.; Suttle, J.; Law, T.; Ng, A.; Muskovic, W.; Norris, M.; Revesz, T.; Osborn, M.; Moore, A.; Suppiah, R.; Fraser, C.; Alvaro, F.; Hughes, T.; Mullighan, C.; Marshall, G.; Dalla Pozza, L.; Yeung, D.; Sutton, R.; White, D.; 57th Annual Meeting of the American Society of Hematology (05 Dec 2015 - 08 Dec 2015 : Orlando, FL)